For example, some reports showed a high concordance (77%) of KRAS variant between tumor tissues and plasma [21], and concordance between tissue and blood ctDNA ranged from 63.2% (APC) to 85.5% (BRAF) in CRC [22]. This evidence concerns the gene KRAS and neoplasm.